(VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.
Microchimerism ("blending" of cells) during pregnancy can confer genetic risks for rheumatoid arthritis in unexpected ways, according to this research on women with the disorder. It may also affect the risk for some men.
The firm Cadila is launching its biosimilar Exemptia in India for about 1/5 the price tag of Abbot's Humira. Most biosimilars to date are sold at roughly two-thirds the cost of the FDA-approved versions.
(ACR2014) Top picks from RheumatologyNetwork Editorial Board members. Nancy Lane MD liked a mouse study that inquires why so many arthritis patients continue to experience pain despite rheumatology's success at conquering inflammation.
(ACR2014) (VIDEO) The National Institutes of Health's PROMIS measures, created to study health status in the general population, look good for meaningful outcomes assessment in diseases such as rheumatoid arthritis, says an expert who studies measurement of disability in rheumatic disorders..